SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-008815
Filing Date
2019-05-15
Accepted
2019-05-15 16:07:07
Documents
1
Period of Report
2019-05-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5229
  Complete submission text file 0001213900-19-008815.txt   6627
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 300 EAST 56TH STREET, APT 19E NEW YORK, NY 10022
Business Address
Kelly Paul Edward (Reporting) CIK: 0001658544 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55347 | Film No.: 19828087